Alliance Global Partners raised the firm’s price target on Myomo (MYO) to $6.75 from $6 and keeps a Buy rating on the shares after the company reported Q4 results that were ahead of the firm’s expectations given strong unit growth for the MyoPro orthotic arm brace. Following earnings, the firm cites higher revenue forecasts for its increased price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYO:
Questions or Comments about the article? Write to editor@tipranks.com